Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
EP1771190A2
Method of producing fully carbamylated erythropoietin
WO2006014466A2
Novel carbamylated epo and method for its production
CN1897960A
Tissue protective cytokines for protection, restoration, and enhancement of responsive cells, tissues and organs with extended therapeutic window
KR20060084844A
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
MXPA05012515A
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window.
ZA200508434B
Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
US7718363B2
Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
EP1575528A2
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
CA2491567A1
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
CN1688883A
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
US7767643B2
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
BR0116587A
Use of an erythropoietin, pharmaceutical composition, methods for protecting, maintaining or enhancing the viability of a cell, tissue or organ isolated from a mammalian body, to facilitate trancitosis of a molecule through a cellular endothelial barrier in a mammal, composition for transport. a molecule via trancitose through a cellular endothelial barrier, and, composition
US6531121B2
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
US7345019B1
Modulation of excitable tissue function by peripherally administered erythropoietin
US7309687B1
Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin
UA89468C2
Modulation of excitable tissue function by peripherally administered erythropoietin
